Complement activation by hydroxyethylmethacrylate‐ethylmethacrylate copolymers
- 1 July 1987
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research
- Vol. 21 (7) , 843-859
- https://doi.org/10.1002/jbm.820210703
Abstract
Certain biomaterials, including nylon oxygenator and cellulosic dialysis membranes, are potent activators of human complement. In this study, the effect of polymers containing 2-hydroxyethyl methacrylate (HEMA) on the human complement system was investigated. Copolymers of HEMA with ethylmethacrylate (EMA) varying from 100 to 40% HEMA in the monomer made by radiation initiation were used to coat glass discs. These were equilibrated with human plasma in vitro and the degree of complement activation was quantitated by C3a radio immunoassay. Significant activation was caused by copolymers made from monomers containing 60% or greater HEMA. A direct relationship between the amount of activation and the percentage of HEMA was found. The degree of activation by poly HEMA, when corrected for surface area, was quite similar to that observed for dialysis and oxygenator membranes. Similar observations were made when solid casts of crosslinked HEMA/N-vinylpyrrolidone (NVP) copolymer gels were tested, but the magnitude of activation was much greater. The results are significant because complement activation may play an important role in the response to foreign surfaces, in both extravascular and intravascular settings. A new concept of molecular biocompatibility is proposed in which surfaces eliciting molecular transformations in any of the biological defense systems are deemed nonbiocompatible. By this criterion, the hydrogel poly-HEMA, which has so frequently been thought of as biocompatible, is considered to be a molecularly nonbiocompatible material.This publication has 46 references indexed in Scilit:
- Anticomplementary activity of dextran derivativesBiomaterials, 1985
- Complement activation by polymer binding IgGBiomaterials, 1984
- Reduction in complement activation from biomaterials by removal of air nuclei from the surface roughnessJournal of Biomedical Materials Research, 1984
- Heparin prevents formation of the human C3 amplification convertase by inhibiting the binding site for B on C3bMolecular Immunology, 1983
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981
- Structural Determinants of the Capacity of Heparin to Inhibit the Formation of the Human Amplification C3 ConvertaseJournal of Clinical Investigation, 1981
- Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.Journal of Clinical Investigation, 1977
- Complement and Leukocyte-Mediated Pulmonary Dysfunction in HemodialysisNew England Journal of Medicine, 1977
- Bovine Plasma Protein Adsorption onto Radiation-Grafted Hydrogels Based on Hydroxyethyl Methacrylate and N-VinylpyrrolidonePublished by American Chemical Society (ACS) ,1975
- Stimulation of DNA synthesis in mouse lymphoid cells by polyanions in vitro. I. Target cells and possible mode of actionEuropean Journal of Immunology, 1973